These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2081897)

  • 1. Preliminary communication. A double-blind placebo-controlled trial of L-tryptophan to assess the degree of cognitive and behavioural improvement in patients with Alzheimer-type dementia and to compare differential response in clinical sub-groups.
    Bentham PW
    Int Clin Psychopharmacol; 1990 Oct; 5(4):261-72. PubMed ID: 2081897
    [No Abstract]   [Full Text] [Related]  

  • 2. L-deprenyl in the treatment of mild dementia of the Alzheimer type: results of a 15-month trial.
    Burke WJ; Roccaforte WH; Wengel SP; Bayer BL; Ranno AE; Willcockson NK
    J Am Geriatr Soc; 1993 Nov; 41(11):1219-25. PubMed ID: 8227897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-deprenyl in the treatment of mild dementia of the Alzheimer type: preliminary results.
    Burke WJ; Ranno AE; Roccaforte WH; Wengel SP; Bayer BL; Willcockson NK
    J Am Geriatr Soc; 1993 Apr; 41(4):367-70. PubMed ID: 8463521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-deprenyl in Alzheimer's disease: cognitive and behavioral effects.
    Freedman M; Rewilak D; Xerri T; Cohen S; Gordon AS; Shandling M; Logan AG
    Neurology; 1998 Mar; 50(3):660-8. PubMed ID: 9521253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral physostigmine treatment for patients with presenile and senile dementia of the Alzheimer's type: a double-blind placebo-controlled trial.
    Jenike MA; Albert MS; Heller H; Gunther J; Goff D
    J Clin Psychiatry; 1990 Jan; 51(1):3-7. PubMed ID: 2403997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acute tryptophan depletion on cognitive function in Alzheimer's disease and in the healthy elderly.
    Porter RJ; Lunn BS; O'Brien JT
    Psychol Med; 2003 Jan; 33(1):41-9. PubMed ID: 12537035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.
    Small G; Erkinjuntti T; Kurz A; Lilienfeld S
    CNS Drugs; 2003; 17(12):905-14. PubMed ID: 12962529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of nicotine in dermal plaster on cognitive functions in patients with Alzheimer's disease.
    Snaedal J; Johannesson T; Jonsson JE; Gylfadottir G
    Dementia; 1996; 7(1):47-52. PubMed ID: 8788082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study.
    Senin U; Abate G; Fieschi C; Gori G; Guala A; Marini G; Villardita C; Parnetti L
    Eur Neuropsychopharmacol; 1991 Dec; 1(4):511-7. PubMed ID: 1822317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease.
    Xu SS; Gao ZX; Weng Z; Du ZM; Xu WA; Yang JS; Zhang ML; Tong ZH; Fang YS; Chai XS
    Zhongguo Yao Li Xue Bao; 1995 Sep; 16(5):391-5. PubMed ID: 8701750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment.
    Tsai GE; Falk WE; Gunther J; Coyle JT
    Am J Psychiatry; 1999 Mar; 156(3):467-9. PubMed ID: 10080566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Alzheimer's disease with stabilized oral nicotinamide adenine dinucleotide: a randomized, double-blind study.
    Demarin V; Podobnik SS; Storga-Tomic D; Kay G
    Drugs Exp Clin Res; 2004; 30(1):27-33. PubMed ID: 15134388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety.
    Wilson AL; Langley LK; Monley J; Bauer T; Rottunda S; McFalls E; Kovera C; McCarten JR
    Pharmacol Biochem Behav; 1995; 51(2-3):509-14. PubMed ID: 7667377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hormone therapy on depressive symptoms and cognitive functions in women with Alzheimer disease: a 12 month randomized, double-blind, placebo-controlled study of low-dose estradiol and norethisterone.
    Valen-Sendstad A; Engedal K; Stray-Pedersen B; ; Strobel C; Barnett L; Meyer N; Nurminemi M
    Am J Geriatr Psychiatry; 2010 Jan; 18(1):11-20. PubMed ID: 20094015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Supplementation of a Whey Peptide Rich in Tryptophan-Tyrosine-Related Peptides on Cognitive Performance in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Study.
    Kita M; Obara K; Kondo S; Umeda S; Ano Y
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 30011836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer-type dementia and verbal memory performances: influence of selegiline therapy.
    Finali G; Piccirilli M; Oliani C; Piccinin GL
    Ital J Neurol Sci; 1992 Mar; 13(2):141-8. PubMed ID: 1592575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term efficacy and tolerability of donepezil in patients with vascular dementia.
    Wilkinson D; Róman G; Salloway S; Hecker J; Boundy K; Kumar D; Posner H; Schindler R
    Int J Geriatr Psychiatry; 2010 Mar; 25(3):305-13. PubMed ID: 19623601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of oral pyridostigmine on memory and cognitive function in SDAT.
    Molloy DW; Cape RD
    Neurobiol Aging; 1989; 10(2):199-204. PubMed ID: 2657467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial.
    Raskind MA; Peskind ER; Truyen L; Kershaw P; Damaraju CV
    Arch Neurol; 2004 Feb; 61(2):252-6. PubMed ID: 14967774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.